Published in Am J Hum Genet on November 01, 1989
Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest (1990) 2.35
Current developments in molecular monitoring in chronic myeloid leukemia. Ther Adv Hematol (2016) 0.75
Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature (1973) 15.28
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell (1984) 6.78
The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science (1985) 6.63
An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell (1984) 4.78
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci U S A (1988) 4.40
Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature (1984) 4.30
Structural organization of the bcr gene and its role in the Ph' translocation. Nature (1985) 4.08
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell (1986) 3.59
The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med (1988) 2.93
Fusion of an immunoglobulin variable gene and a T cell receptor constant gene in the chromosome 14 inversion associated with T cell tumors. Cell (1985) 1.87
Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science (1987) 1.76
The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia. Mol Cell Biol (1987) 1.73
The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients. Blood (1988) 1.42
A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene. Nature (1988) 1.32
Common mechanism of chromosome inversion in B- and T-cell tumors: relevance to lymphoid development. Science (1986) 1.21
Evidence that the phl gene encodes a 160,000-dalton phosphoprotein with associated kinase activity. Mol Cell Biol (1987) 1.18
Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia patient. Proc Natl Acad Sci U S A (1989) 1.14
bcr-abl RNA in patients with chronic myelogenous leukemia. Blood (1987) 1.07
bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia (1988) 1.02
Characteristics of the terminal phase of chronic granulocytic leukemia. Blood (1968) 1.00
Analysis of a T-cell tumor-specific breakpoint cluster at human chromosome 14q32. Proc Natl Acad Sci U S A (1988) 0.99
Localization of preferential sites of rearrangement within the BCR gene in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (1989) 0.97
Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction. Blood (1988) 0.96
Molecular cloning of a 5' segment of the genomic phl gene defines a new breakpoint cluster region (bcr2) in Philadelphia-positive acute leukemias. Leukemia (1988) 0.93
The first BCR gene intron contains breakpoints in Philadelphia chromosome positive leukemia. Nucleic Acids Res (1988) 0.93
Cytogenetic studies in acute myelocytic leukemia with special emphasis on the occurrence of Ph1 chromosome. Blood (1970) 0.92
Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reaction. Blood (1988) 0.86
Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia. Leukemia (1988) 0.84
Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies. Blood (1988) 0.83
Utility of molecular genetic analysis of bcr rearrangement in the diagnosis of chronic myeloid leukemia. Cancer Genet Cytogenet (1987) 0.82
Philadelphia chromosome in acute lymphocytic leukemia. Blood (1970) 0.82
Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemia. Blood (1988) 0.81
The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia. Leukemia (1988) 0.80
Historical communication: Philadelphia-positive chronic myelogenous leukemia followed for 27 years. Cancer Genet Cytogenet (1988) 0.80
Molecular abnormalities of bcr and c-abl in chronic myelogenous leukemia associated with a long chronic phase. Blood (1988) 0.78
Philadelphia chromosome positive childhood acute lymphoblastic leukemia. Blood (1980) 0.78
Philadelphia-positive chronic myelogenous leukemia with breakpoint 5' of the breakpoint cluster region but within the bcr gene. Blut (1987) 0.77
A rare restriction enzyme site polymorphism in the breakpoint cluster region (bcr) of chromosome 22. Leukemia (1988) 0.77
Philadelphia-positive chronic myeloid leukemia with a chromosome 22 breakpoint outside the breakpoint cluster region. Blood (1987) 0.76
The karyotype of Philadelphia chromosome-negative, bcr rearrangement-positive chronic myeloid leukemia. Cancer Genet Cytogenet (1988) 0.76
Absence of alternative splicing in bcr-abl mRNA in chronic myeloid leukemia cell lines. Blood (1988) 0.76
Rapid progress in chronic myelogenous leukemia. Leukemia (1988) 0.76
Restriction fragment length polymorphism of bcr in Japanese patients with hematological malignancies. Leukemia (1988) 0.76
Cohort study analysis with a FORTRAN computer program. Int J Epidemiol (1986) 6.66
Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N Engl J Med (1992) 4.54
Initial symptoms of nicotine dependence in adolescents. Tob Control (2000) 4.22
Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet (1999) 3.93
Development of symptoms of tobacco dependence in youths: 30 month follow up data from the DANDY study. Tob Control (2002) 3.64
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib. Leukemia (2008) 3.58
Plasticity of face processing in infancy. Proc Natl Acad Sci U S A (2005) 2.97
A clinical study of the lupus anticoagulant. Blood (1976) 2.81
Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood (1968) 2.71
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Ann Oncol (2003) 2.63
The practice of neurology, 2000-2010: report of the AAN Member Research Subcommittee. Neurology (2011) 2.59
Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol (1997) 2.43
Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol (1987) 2.34
Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A (1985) 2.33
Extent of misclassification of death from Creutzfeldt-Jakob disease in England 1979-96: retrospective examination of clinical records. BMJ (2000) 2.32
Primary pulmonary hypertension in a patient with CD8/T-cell large granulocyte leukemia: amelioration by cladribine therapy. Chest (1997) 2.32
Comparison of high resolution chromosome banding and fluorescence in situ hybridization (FISH) for the laboratory evaluation of Prader-Willi syndrome and Angelman syndrome. Am J Med Genet (1994) 2.30
Broad-spectrum mildew resistance in Arabidopsis thaliana mediated by RPW8. Science (2001) 2.23
The simplest walking model: stability, complexity, and scaling. J Biomech Eng (1998) 2.21
Insecticide resistance in Anopheles funestus (Diptera: Culicidae) from Mozambique. J Med Entomol (2006) 2.20
Sources of tobacco for youths in communities with strong enforcement of youth access laws. Tob Control (2001) 2.13
The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER). Ann Oncol (2012) 2.09
Thought disorder in the relatives of psychotic patients. Arch Gen Psychiatry (1989) 2.06
CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol (2004) 1.97
Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science (1981) 1.84
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology (Oxford) (2003) 1.83
Specific chromosome aberrations in senescent fibroblast cell lines derived from human embryos. Am J Hum Genet (1976) 1.82
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood (1982) 1.79
Variability in cytokine and cell adhesion molecule staining in arthroscopic synovial biopsies: quantification using color video image analysis. J Rheumatol (1997) 1.77
Cancer prevalence in European registry areas. Ann Oncol (2002) 1.72
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood (1981) 1.68
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
Site-directed isotope labelling and FTIR spectroscopy of bacteriorhodopsin. Nat Struct Biol (1994) 1.67
Pathogenic mechanisms in the rheumatoid nodule: comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient. Arthritis Rheum (1998) 1.66
Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. N Engl J Med (1985) 1.61
Antigenic variation in current human type A influenza viruses: antigenic characteristics of the variants and their geographic distribution. Bull World Health Organ (1973) 1.60
Insecticide resistance in Anopheles arabiensis and Anopheles gambiae from Mozambique. J Med Entomol (2006) 1.55
Electroretinograms in autism: a pilot study of b-wave amplitudes. Am J Psychiatry (1988) 1.54
Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. The Cancer and Leukemia Group B. Cancer (1992) 1.44
Chromosomal polymorphisms of 1, 9, 16, and Y in 4 major ethnic groups: a large prenatal study. Am J Med Genet (1987) 1.41
Melphalan and prednisone plus total bone marrow irradiation as initial treatment for multiple myeloma. Int J Radiat Oncol Biol Phys (1988) 1.41
Plight of Afghan people must not be forgotten. BMJ (2001) 1.41
Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B study. J Clin Oncol (1983) 1.38
Patients' knowledge of perioperative care. Ir J Med Sci (2000) 1.38
Multicentric angiofollicular lymph node hyperplasia with peripheral neuropathy, pseudotumor cerebri, IgA dysproteinemia, and thrombocytosis in women. A distinct syndrome. Ann Intern Med (1990) 1.38
Cytogenetically marked clones in human fibroblasts cultured from normal subjects. Somatic Cell Genet (1976) 1.37
Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J Natl Cancer Inst (1995) 1.36
The gelatinous bone marrow (serous atrophy) in patients with acquired immunodeficiency syndrome. Evidence of excess sulfated glycosaminoglycan. Arch Pathol Lab Med (1992) 1.31
Autism and medical disorders: a review of the literature. Dev Med Child Neurol (1996) 1.28
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. Cancer J Sci Am (2006) 1.27
Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer (2005) 1.26
Leukaemia incidence in electrical workers. Lancet (1983) 1.24
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood (1994) 1.22
Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood (1998) 1.22
A randomized placebo-controlled trial of arthroscopic lavage versus lavage plus intra-articular corticosteroids in the management of symptomatic osteoarthritis of the knee. Rheumatology (Oxford) (2003) 1.22
The importance of bone marrow biopsy in the staging of patients with lymphosarcoma. Blood (1973) 1.20
Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia. Blood (1980) 1.18
Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids. Behav Pharmacol (2005) 1.17
The diagnosis of miliary tuberculosis: utility of peripheral blood abnormalities, bone marrow and liver needle biopsy. J Chronic Dis (1973) 1.17
Cytokine abundance in placental tissues: evidence of inflammatory activation in gestational membranes with term and preterm parturition. Am J Obstet Gynecol (1999) 1.17
Aggressive plasma cell myeloma. A terminal phase. Arch Intern Med (1981) 1.17
Pericardial tamponade: a major presenting manifestation of hydralazine-induced lupus syndrome. Am J Med (1973) 1.16
Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol (2008) 1.15
Endogenous opiate receptor ligand: electrically induced release in the guinea pig ileum. Science (1977) 1.14
A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. J Clin Oncol (1988) 1.13
Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. J Natl Cancer Inst (1993) 1.12
Results of the American Academy of Neurology resident survey. Neurology (2011) 1.12
Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocr Relat Cancer (2006) 1.11
Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsies. Rheumatology (Oxford) (2001) 1.11
Fibrochondrogenesis: lethal, autosomal recessive chondrodysplasia with distinctive cartilage histopathology. Am J Med Genet (1984) 1.09
Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome. J Clin Invest (1995) 1.09
Proposed guidelines for diagnosis of chromosome mosaicism in amniocytes based on data derived from chromosome mosaicism and pseudomosaicism studies. Prenat Diagn (1992) 1.09
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies. Ann Oncol (2008) 1.09
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. J Clin Oncol (1996) 1.07
Antithymocyte globulin reacts with many normal human cell types. Blood (1983) 1.06
Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure. Medicine (Baltimore) (1988) 1.06
Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. Ann Rheum Dis (2003) 1.06
Changes in synovial tissue Jak-STAT expression in rheumatoid arthritis in response to successful DMARD treatment. Ann Rheum Dis (2006) 1.05
Respiratory disease in Utah coal miners. Am Rev Respir Dis (1981) 1.05
Pulmonary alveolar proteinosis: an uncommon cause of chronic neonatal respiratory distress. Am Rev Respir Dis (1980) 1.05
Haemagglutinin relationships of Hong Kong(H3) and Asian(H2) influenza strains delineated by antigen-specific recombinants. J Gen Virol (1972) 1.05
Uveitis, cutaneous and neurosarcoid: treatment with low-dose cyclosporine A. Transplant Proc (1988) 1.04
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B. Ann Oncol (1998) 1.04
JAK2 Mutations are present in all cases of polycythemia vera. Leukemia (2007) 1.04
Dominant thalassemia-like phenotypes associated with mutations in exon 3 of the beta-globin gene. Blood (1992) 1.03
Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen. Ann Intern Med (1982) 1.03
Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis. Reduced E-selectin and intercellular adhesion molecule 1 expression. Arthritis Rheum (1996) 1.03
Scoring manual for the Thought Disorder Index. Schizophr Bull (1986) 1.02
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study. Br J Cancer (2008) 1.02
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study. Cancer Chemother Pharmacol (1995) 1.02
Biological and immunological characterization of ATG and ALG. Blood (1986) 1.02
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study. Am J Clin Oncol (1984) 1.02
Deoxycytidine and deoxythymidine kinase activities in plasma of mice and patients with neoplastic disease. Cancer Res (1982) 1.01
Characteristics of the terminal phase of chronic granulocytic leukemia. Blood (1968) 1.00
Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells. Cancer Res (1977) 1.00
Effect of omega-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice. Clin Cancer Res (1996) 1.00
The chlorine isotope composition of Earth's mantle. Science (2008) 0.99
Immunologic abnormalities in myelofibrosis with activation of the complement system. Blood (1981) 0.99